首页 | 本学科首页   官方微博 | 高级检索  
检索        


Effect of adding vildagliptin to insulin in haemodialysed patients with type 2 diabetes: The VILDDIAL study,a randomized,multicentre, prospective study
Authors:Marion Munch MD  Laurent Meyer MD  Thierry Hannedouche MD  Kristian Kunz MD  Farideh Alenabi MD  Patrice Winiszewski MD  Philippe Baltzinger MD  Agnès Smagala MD  Alexandre Klein MD  François Dorey MD  Dominique Fleury MD  Odile Verier-Mine MD  Bruno Guerci MD  Joëlle Cridlig MD  Sophie Borot MD  Didier Ducloux MD  Nicolas Meyer MD  Samy Hadjadj MD  François Chantrel MD  Laurence Kessler MD
Institution:1. CHU Strasbourg, Department of Diabetology, Strasbourg, Alsace, France;2. CHU Strasbourg, Department of Nephrology, Strasbourg, Alsace, France;3. AURAL, Nephrology, Strasbourg, Alsace, France;4. CH Mulhouse, Department of Diabetology, Mulhouse, Grand Est, France;5. CH Colmar, Department of Diabetology, Alsace, France;6. CH Colmar, Department of Nephrology, Alsace, France;7. CH Valenciennes, Department of Diabetology, Nord, France;8. CH Valenciennes, Department of Nephrology, Nord, France;9. CHU Nancy, Department of Diabetology, Lorraine, France;10. CHU Nancy, Department of Nephrology, Lorraine, France;11. CHU Besançon, Department of Diabetology, Franche Comté, France;12. CHU Besançon, Department of Nephrology, Franche Comté, France;13. Strasbourg University Teaching Hospital, Federation of Translational Medicine, Strasbourg, France;14. Department of Diabetology, University Hospital of Nantes, Nantes, France;15. CH Mulhouse, Department of Nephrology, Mulhouse, Alsace, France
Abstract:
Keywords:continuous glucose monitoring  haemodialysis  insulin treatment  type 2 diabetes  vildagliptin
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号